We demonstrated in this study that the Spred2 KO mice exhibited an exacerbated level of adipocyte hypertrophy and hyperlipidemia (elevated levels of cholesterol, triglyceride, and FFA), suggesting that Spred2 negatively regulates adipocyte hypertrophy and hyperlipidemia. This evidence concerns the gene SPRED2 and hyperlipidemia.